APPL1
DCC-interacting protein 13-alpha
Also known as: APPL, DP13A_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UKG1
- Gene
- APPL1
- Ensembl
- ENSG00000157500
- Chromosome
- 3
- Canonical length
- 709 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Vesicles,Plasma membrane,Actin filaments,Cytosol
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene has been shown to be involved in the regulation of cell proliferation, and in the crosstalk between the adiponectin signalling and insulin signalling pathways. The encoded protein binds many other proteins, including RAB5A, DCC, AKT2, PIK3CA, adiponectin receptors, and proteins of the NuRD/MeCP1 complex. This protein is found associated with endosomal membranes, but can be released by EGF and translocated to the nucleus. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
709 residues, UniProt reviewed canonical sequence.
>Q9UKG1|APPL1
1 MPGIDKLPIE ETLEDSPQTR SLLGVFEEDA TAISNYMNQL YQAMHRIYDA QNELSAATHL
61 TSKLLKEYEK QRFPLGGDDE VMSSTLQQFS KVIDELSSCH AVLSTQLADA MMFPITQFKE
121 RDLKEILTLK EVFQIASNDH DAAINRYSRL SKKRENDKVK YEVTEDVYTS RKKQHQTMMH
181 YFCALNTLQY KKKIALLEPL LGYMQAQISF FKMGSENLNE QLEEFLANIG TSVQNVRREM
241 DSDIETMQQT IEDLEVASDP LYVPDPDPTK FPVNRNLTRK AGYLNARNKT GLVSSTWDRQ
301 FYFTQGGNLM SQARGDVAGG LAMDIDNCSV MAVDCEDRRY CFQITSFDGK KSSILQAESK
361 KDHEEWICTI NNISKQIYLS ENPEETAARV NQSALEAVTP SPSFQQRHES LRPAAGQSRP
421 PTARTSSSGS LGSESTNLAA LSLDSLVAPD TPIQFDIISP VCEDQPGQAK AFGQGGRRTN
481 PFGESGGSTK SETEDSILHQ LFIVRFLGSM EVKSDDHPDV VYETMRQILA ARAIHNIFRM
541 TESHLLVTCD CLKLIDPQTQ VTRLTFPLPC VVLYATHQEN KRLFGFVLRT SSGRSESNLS
601 SVCYIFESNN EGEKICDSVG LAKQIALHAE LDRRASEKQK EIERVKEKQQ KELNKQKQIE
661 KDLEEQSRLI AASSRPNQAS SEGQFVVLSS SQSEESDLGE GGKKRESEALocalizationUniProt · AlphaFold · HPA
Whether an antibody against APPL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.38
- Highest tissue expression
- 41 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 41 nTPM
- pancreas: 28 nTPM
- tongue: 25 nTPM
- parathyroid gland: 24 nTPM
- heart muscle: 23 nTPM
- ovary: 19 nTPM
Single-cell type
- sertoli cells: 247 nCPM
- pancreatic acinar cells: 221 nCPM
- myonuclei: 214 nCPM
- monocyte progenitors: 163 nCPM
- neutrophil progenitors: 155 nCPM
- esophageal suprabasal cells: 142 nCPM
Immune cell
- naive B-cell: 28 nTPM
- memory B-cell: 18 nTPM
- plasmacytoid DC: 18 nTPM
- myeloid DC: 11 nTPM
- NK-cell: 7.4 nTPM
- classical monocyte: 5.3 nTPM
Brain region
- cerebellum: 26 nTPM
- hypothalamus: 23 nTPM
- spinal cord: 21 nTPM
- white matter: 21 nTPM
- thalamus: 20 nTPM
- midbrain: 20 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about APPL1.
Disease | AllUniProt
Conditions APPL1 is implicated in, by any mechanism.
- Maturity-onset diabetes of the young 14 (MODY14) MIM:616511
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 273 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Maturity-onset diabetes of the young type 14
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.35
- gnomAD pLI
- 0.8
- gnomAD missense Z
- 0.72
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adiponectin-activated signaling pathway
- cellular response to hepatocyte growth factor stimulus
- insulin receptor signaling pathway
- maintenance of synapse structure
- positive regulation of cytokine production involved in inflammatory response
- positive regulation of D-glucose import
- positive regulation of macropinocytosis
- positive regulation of melanin biosynthetic process
- protein import into nucleus
- regulation of D-glucose import
- regulation of fibroblast migration
- regulation of G1/S transition of mitotic cell cycle
- regulation of innate immune response
- regulation of protein localization to plasma membrane
- regulation of toll-like receptor 4 signaling pathway
- signal transduction
- signaling
- transforming growth factor beta receptor signaling pathway
- negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis
Molecular functions
- beta-tubulin binding
- identical protein binding
- phosphatidylinositol binding
- phosphatidylserine binding
- protein homodimerization activity
- protein kinase B binding
- protein-containing complex binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Pleckstrin homology domain
- BAR domain
- PTB/PI domain
- PH-like domain superfamily
- AH/BAR domain superfamily
- DCC-interacting protein 13-alpha/beta
- DCC-interacting protein 13-alpha/beta, PH domain
- DCC-interacting protein 13-alpha/beta, PTB domain
- PH domain
- Phosphotyrosine interaction domain (PTB/PID)
- BAR domain of APPL family
- DCC-interacting protein 13-alpha, BAR domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of APPL1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads APPL1 as an antibody target. Whether an autoantibody or antibody against APPL1 could matter depends on whether native APPL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
APPL1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label APPL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...